Home›Companies›Biotech & Pharma›Courage Therapeutics

Courage Therapeutics, Inc.

Updated Oct 29, 2026·Latest SEC filing May 22, 2025·Suggest an edit

About Courage Therapeutics

Courage Therapeutics is a private company based in Newton, Massachusetts. It has reported $4,510,963 raised in one offering on Form D since May 2025. Its chief executive is Daniel Housman.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 30, 2025May 22, 2025$4,510,963of $10.4M target14$322KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Courage Therapeutics's Form D filed May 22, 2025.

IB
RC
Roger Cone
Director
BL
DH
Daniel Housman
Chief Executive Officer and director

Sources

  1. SECCOURAGE THERAPEUTICS, INC. filing history